Executive Summary
Period Overview: Q1 2025 represents the initial operational period for Alvio Labs, with the company recording its first financial activities. The quarter shows a net loss of EUR 10,966.85, which is expected for a newly established entity in its startup phase.
Key Highlights:
- Total operating expenses of EUR 616.85, primarily in consulting and R&D
- Cost of goods sold at EUR 10,350.00
- Bank balance of EUR 532.14 as of March 31, 2025
- Director loans totaling EUR 14,543.09 providing working capital support
Outlook: The company is in early-stage operations with minimal revenue generation. Focus should be on establishing revenue streams and managing burn rate.
1. Financial Overview
1.1 Key Performance Indicators
|
Net Profit / Loss
(EUR 10,966.85)
|
Gross Profit
(EUR 10,350.00)
|
Operating Expenses
EUR 616.85
|
|
Cash Position
EUR 532.14
|
Total Assets
EUR 532.14
|
Net Assets
(EUR 14,416.85)
|
1.2 Profit & Loss Summary
| Item | Amount (EUR) | % of Revenue |
|---|---|---|
| Revenue | - | - |
| Less: Cost of Goods Sold | (10,350.00) | - |
| Gross Profit | (10,350.00) | - |
| Bank Fees | (10.00) | - |
| Consulting & Accounting | (405.90) | - |
| Office: Software Expenses | (2.68) | - |
| Research & Development | (198.27) | - |
| Total Operating Expenses | (616.85) | - |
| NET PROFIT / (LOSS) | (EUR 10,966.85) | - |
2. Revenue Analysis
Revenue Status
During Q1 2025, Alvio Labs did not record any revenue transactions. This is consistent with the company's early-stage status as it establishes operations and develops its product/service offerings.
2.1 Revenue by Category
| Revenue Category | Q1 2025 (EUR) | % of Total | Notes |
|---|---|---|---|
| Product Sales | - | - | No sales recorded |
| Service Revenue | - | - | No services billed |
| Other Income | - | - | - |
| Total Revenue | - | - |
2.2 Revenue Trend Analysis
As this is the first quarter of operations, no comparative trend data is available. Revenue generation is expected to commence in subsequent quarters as the company moves from development to commercialization.
3. Expense Analysis
3.1 Operating Expense Breakdown
| Expense Category | Amount (EUR) | % of Total | Visual |
|---|---|---|---|
| Consulting & Accounting | 405.90 | 65.8% | |
| Research & Development | 198.27 | 32.1% | |
| Bank Fees | 10.00 | 1.6% | |
| Office: Software Expenses | 2.68 | 0.4% | |
| Total Operating Expenses | 616.85 | 100.0% |
3.2 Cost of Goods Sold
| Item | Amount (EUR) | Description |
|---|---|---|
| Cost of Goods Sold | 10,350.00 | Direct costs associated with product/service delivery |
| Total Cost of Sales | 10,350.00 |
3.3 Expense Trends & Observations
- Consulting & Accounting (65.8%): The largest expense category reflects professional services required for company setup, compliance, and financial management.
- R&D Investment (32.1%): Significant allocation to research and development indicates focus on product development and innovation.
- Operational Efficiency: Bank fees and software expenses are minimal, indicating lean operational infrastructure.
4. Cash Flow Summary
4.1 Cash Position
| Account | Balance (EUR) | Status |
|---|---|---|
| Revolut EUR Main | 532.14 | Active |
| Total Cash & Bank | 532.14 |
4.2 Cash Flow Analysis
| Category | Amount (EUR) | Flow |
|---|---|---|
| Director Loans (Inflow) | 800.00 | |
| Revenue Commission (Inflow) | 40.00 | |
| Operating Expenses (Outflow) | (307.86) | |
| Net Cash Movement | 532.14 |
4.3 Working Capital
| Item | Amount (EUR) |
|---|---|
| Current Assets | 532.14 |
| Current Liabilities | (14,948.99) |
| Working Capital | (14,416.85) |
Working Capital Note
The negative working capital position is primarily due to director loans (EUR 14,543.09) which provide essential funding during the startup phase. These liabilities represent related-party financing rather than external debt.
5. Key Financial Ratios
5.1 Profitability Ratios
| Ratio | Value | Benchmark |
|---|---|---|
| Net Profit Margin | N/A | No revenue |
| Gross Profit Margin | N/A | No revenue |
| Operating Expense Ratio | N/A | No revenue |
Note: Profitability ratios cannot be calculated without revenue. These will be meaningful once sales commence.
5.2 Liquidity Ratios
| Ratio | Value | Assessment |
|---|---|---|
| Current Ratio | 0.04 | Below 1.0 - Limited liquidity |
| Quick Ratio | 0.04 | Below 1.0 - Cash constrained |
| Cash Ratio | 0.04 | Dependent on director support |
5.3 Leverage Ratios
| Ratio | Value | Assessment |
|---|---|---|
| Debt-to-Assets | 28.1x | High leverage (director loans) |
| Debt-to-Equity | (1.04) | Negative equity position |
5.4 Efficiency Metrics
| Metric | Value | Notes |
|---|---|---|
| Monthly Burn Rate | EUR 205.62 | Operating expenses / 3 months |
| Runway (months) | 2.6 | Based on current cash position |
6. Balance Sheet Summary
As at March 31, 2025
6.1 Assets
| Item | Amount (EUR) |
|---|---|
| Current Assets | |
| Cash & Bank | 532.14 |
| Total Assets | 532.14 |
6.2 Liabilities
| Item | Amount (EUR) |
|---|---|
| Current Liabilities | |
| Accounts Payable | 405.90 |
| Director's Current Account | 13,993.09 |
| Director's Loan Account | 550.00 |
| Total Liabilities | 14,948.99 |
6.3 Equity
| Item | Amount (EUR) |
|---|---|
| Current Year Earnings | (10,966.85) |
| Retained Earnings | (3,450.00) |
| Total Equity | (14,416.85) |
Balance Sheet Observation
The company shows a negative equity position of EUR 14,416.85, which is typical for early-stage startups. The accumulated losses reflect initial setup costs and operating expenses incurred before revenue generation begins.
7. Management Recommendations
7.1 Immediate Actions
- Revenue Generation: Prioritize activities that generate first revenue streams to improve cash flow and reduce dependency on director loans.
- Expense Management: Continue lean operations while maintaining essential R&D investment for product development.
- Cash Monitoring: Implement weekly cash flow monitoring given the limited runway of 2.6 months.
7.2 Strategic Priorities
- Product Launch: Accelerate timeline to first commercial product/service offering.
- Funding Strategy: Evaluate additional funding options to extend runway beyond current cash position.
- Cost Structure: Review consulting expenses to ensure optimal value for professional services.
7.3 Risk Factors
| Risk | Impact | Mitigation |
|---|---|---|
| Limited Cash Runway | High | Secure additional funding or accelerate revenue |
| No Revenue Generation | High | Focus on MVP completion and customer acquisition |
| Dependency on Director Loans | Medium | Diversify funding sources |
Document Information:
This report was generated from Xero accounting data for Alvio Labs covering the period January 1 - March 31, 2025. All figures are presented in EUR. This document is confidential and intended for board use only.
Data Source: Xero Accounting Software | Report Date: March 22, 2026